PPP1R12A and atrial fibrillation: ROCK inhibitor fasudil treatment reduces phosphorylated MYPT-1 levels, subsequently decreasing Cx40 protein expression and improving cardiac function; in-depth exploration of the ROCK pathway in AF may elucidate arrhythmogenic mechanisms, positioning Rho kinase inhibitors as potential therapeutic targets [47];